The University of Pittsburgh Has Joined the NGD Consortium

PRESS RELEASE
Written By Casey-Drew Williams

Next Gen Diagnostics Announces that the University of Pittsburgh Has Joined the NGD Consortium.

Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based determination of bacterial antibiotic susceptibility, today announces that the University of Pittsburgh (Pitt) has joined the NGD Consortium, a part of NGD’s effort (1) to develop a sequence-based diagnostic model to predict susceptibility to cefiderocol, an antibiotic developed by Shionogi & Co., Ltd. (Shionogi).

Casey-Drew Williams
Next

Next Gen Diagnostics and Sheba Medical Center Announce Agreement for NGD to Sequence and Analyze Unique Collection of Highly Resistant Bacterial Infections